Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

572 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received.
Schnipper LE, Davidson NE, Wollins DS, Blayney DW, Dicker AP, Ganz PA, Hoverman JR, Langdon R, Lyman GH, Meropol NJ, Mulvey T, Newcomer L, Peppercorn J, Polite B, Raghavan D, Rossi G, Saltz L, Schrag D, Smith TJ, Yu PP, Hudis CA, Vose JM, Schilsky RL. Schnipper LE, et al. Among authors: lyman gh. J Clin Oncol. 2016 Aug 20;34(24):2925-34. doi: 10.1200/JCO.2016.68.2518. Epub 2016 May 31. J Clin Oncol. 2016. PMID: 27247218 No abstract available.
American Society of Clinical Oncology Statement: Biosimilars in Oncology.
Lyman GH, Balaban E, Diaz M, Ferris A, Tsao A, Voest E, Zon R, Francisco M, Green S, Sherwood S, Harvey RD, Schilsky RL. Lyman GH, et al. J Clin Oncol. 2018 Apr 20;36(12):1260-1265. doi: 10.1200/JCO.2017.77.4893. Epub 2018 Feb 14. J Clin Oncol. 2018. PMID: 29443651 Review.
Use of Biosimilar Medications in Oncology.
Nahleh Z, Lyman GH, Schilsky RL, Peterson DE, Tagawa ST, Chavez-MacGregor M, Rumble RB, Gupta S. Nahleh Z, et al. Among authors: lyman gh. JCO Oncol Pract. 2022 Mar;18(3):177-186. doi: 10.1200/OP.21.00771. Epub 2022 Jan 18. JCO Oncol Pract. 2022. PMID: 35041524 Review.
Biosimilar Use Among 38 ASCO PracticeNET Practices, 2019-2021.
Bourbeau B, Lyman GH, Lei XJ, Jones L, Rosenthal J, Kozlik MM, Oettel KR, Tinger A, Page R. Bourbeau B, et al. Among authors: lyman gh. JCO Oncol Pract. 2023 Jul;19(7):516-522. doi: 10.1200/OP.22.00618. Epub 2023 Apr 21. JCO Oncol Pract. 2023. PMID: 37084324
Baseline Estimates of Adherence to American Society of Clinical Oncology/American Board of Internal Medicine Choosing Wisely Initiative Among Patients With Cancer Enrolled With a Large Regional Commercial Health Insurer.
Ramsey SD, Fedorenko C, Chauhan R, McGee R, Lyman GH, Kreizenbeck K, Bansal A. Ramsey SD, et al. Among authors: lyman gh. J Oncol Pract. 2015 Jul;11(4):338-43. doi: 10.1200/JOP.2014.002717. Epub 2015 Jun 9. J Oncol Pract. 2015. PMID: 26060225
572 results